Clinical indications for the investigation of porphyria: Case examples and evolving laboratory approaches to its diagnosis in New Zealand

New Zealand Medical Journal

Volumn 118, Issue 1222, 2005, Pages

  Sies, Christiaan ^a   Florkowski, Christopher ^a   George, Peter ^a   Potter, Howard ^a  

^a CANTERBURY HEALTH LABORATORIES   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; FAMILY HISTORY; FLUORESCENCE ANALYSIS; FLUOROSCOPY; HUMAN; LABORATORY DIAGNOSIS; MENTAL DISEASE; MUTATIONAL ANALYSIS; NEUROLOGIC DISEASE; NEW ZEALAND; PHOTOSENSITIVITY; PORPHYRIA; RASH; SCREENING; ACUTE INTERMITTENT PORPHYRIA; ADULT; AGED; BIOSYNTHESIS; BLOOD; CASE REPORT; CONGENITAL ERYTHROPOIETIC PORPHYRIA; COPROPORPHYRIA; DIAGNOSIS, MEASUREMENT AND ANALYSIS; ERYTHROPOIETIC PROTOPORPHYRIA; FEMALE; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PORPHYRIA CUTANEA TARDA; PORPHYRIA VARIEGATA; PRESCHOOL CHILD; REVIEW;

BIOLOGICAL MARKER; HEME; PORPHYRIN;

ADULT; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CHILD, PRESCHOOL; CLINICAL LABORATORY TECHNIQUES; COPROPORPHYRIA, HEREDITARY; FEMALE; HEME; HUMANS; MALE; MIDDLE AGED; PORPHYRIA CUTANEA TARDA; PORPHYRIA, ACUTE INTERMITTENT; PORPHYRIA, ERYTHROPOIETIC; PORPHYRIA, VARIEGATE; PORPHYRIAS; PORPHYRINS; PROTOPORPHYRIA, ERYTHROPOIETIC;

EID: 27244458060     PISSN: 11758716     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Hift RJ, Meissner PN. An analysis of 112 acute porphyric attacks in Cape Town, South Africa: Evidence that acute intermittent porphyria and variegate porphyria differ in susceptibility and severity. Medicine. 2005;84;48-60.
2. Kauppinen R. Porphyrias. Lancet. 2005;365:241-52.
3. Elder GH, Smith SG, Smyth SJ. Laboratory investigation of porphyrias. Ann Clin Biochem. 1990;27:395-412.
4. Hift RJ, Davidson BP, van der Hooft C, et al. Plasma fluorescence scanning and fecal porphyrin analysis for the diagnosis of variegate porphyria: precise determination of sensitivity and specificity with detection of protoporphyrinogen oxidase mutations as standard. Clin Chem. 2004;50:915-23.
5. Moore MR, Hift RJ. Drugs in the acute porphyrias-toxicogenetic diseases. Cell Mol Biol. 1997;43:89-94.
6. Todd DJ. Erythropoietic protoporphyria. Br J Dermatol 1994;131:751-66.
7. Elder GH. The cutaneous porphyrias. Semin Dermatol. 1990;9:63-9.
8. Watson CJ, Schwartz S. A simple test for urinary porphoblinogen. Proc Soc Exp Biol 1941;47:393-4.
9. Blake D, Poulos V, Rossi R. Diagnosis of porphyria - recommended methods for peripheral laboratories. Clin Biochem Revs. 1992;13(Supplement 1):S1-S24.
10. Poh-Fitzpatrick MB. A plasma porphyrin florescence marker of variegate porphyria. Arch Dermatol. 1980;116:543-7.
11. Long C, Smyth SJ, Woolf J, et al. Detection of latent variegate porphyria by fluorescence emission spectroscopy of plasma. Br J Dermatol. 1993;129:9-13.
12. Whatley SD, Puy H, Morgan RR, et al. Variegate porphyria in Western Europe: identification of PPOX gene mutations in 104 families, extent of allelic heterogeneity, and absence of correlation between phenotype and type of mutation. A J Hum Genet. 1999;65:984-94.
13. Hift RJ, Meissner PN, Corrigall AV, et al. Variegate porphyria in South Africa, 1688-1996-new developments in an old disease. S Afr Med J. 1997;87:722-31.
14. Elder GH. Update on enzyme and molecular defects in porphyria. Photodermatol Photoimmunol Photomed. 1998;14:66-9.
15. Griffith JC, Jardine DL, Bailey W, Florkowski CM. Variegate porphyria presenting with acute autonomic dysfunction, intussusception and renal infarct. Scand J Lab Clin Invest. 2004;39:500-3.
16. Deacon AC, Elder GH. ACP Best practice No 165: front line tests for the investigation of suspected porphyria. J Clin Pathol. 2001;54:500-7.
17. Gouya L, Puy H, Robreau AM, et al. The penetrance of dominant erythropoietic protoporphyria is modulated by expression of wildtype FECH. Nat Genet. 2002;30:27-8.
18. Rossi E, Garcia-Webb P. Red cell zinc protoporphyrin and protoporphyrin by HPLC with fluorescence detection. Biochemical Chromatography. 1986;1:163-8.
19. Morris SD, Mason NG, Elder GH, et al. Ferrochelatse gene polymorphism analysis for accurate gene counselling in erythropoietic protoporphyria. Br J Dermatol. 2002;147:572-4.